These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 9618422

  • 1. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
    Davidkova G, Zhou LW, Morabito M, Zhang SP, Weiss B.
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422
    [Abstract] [Full Text] [Related]

  • 2. Oligodeoxynucleotide antisense to the D1 dopamine receptor mRNA inhibits D1 dopamine receptor-mediated behaviors in normal mice and in mice lesioned with 6-hydroxydopamine.
    Zhang SP, Zhou LW, Weiss B.
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1462-70. PubMed ID: 7996459
    [Abstract] [Full Text] [Related]

  • 3. In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor-mediated behavior and the expression of D2 dopamine receptors in mouse striatum.
    Zhou LW, Zhang SP, Qin ZH, Weiss B.
    J Pharmacol Exp Ther; 1994 Feb; 268(2):1015-23. PubMed ID: 8113958
    [Abstract] [Full Text] [Related]

  • 4. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC, Fukushiro DF, Helfer DC, Callegaro-Filho D, Trombin TF, Zanlorenci LH, Sanday L, Silva RH, Frussa-Filho R.
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [Abstract] [Full Text] [Related]

  • 5. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B, Katz JL, Alling K, Acri JB, Witkin JM.
    J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
    [Abstract] [Full Text] [Related]

  • 6. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS, Joyce JN.
    Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
    [Abstract] [Full Text] [Related]

  • 7. D2 dopamine receptor antisense oligodeoxynucleotide inhibits the synthesis of a functional pool of D2 dopamine receptors.
    Qin ZH, Zhou LW, Zhang SP, Wang Y, Weiss B.
    Mol Pharmacol; 1995 Oct; 48(4):730-7. PubMed ID: 7476901
    [Abstract] [Full Text] [Related]

  • 8. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G, Depoortere R, Morel E, Sanger DJ, Scatton B.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [Abstract] [Full Text] [Related]

  • 9. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG, Jadhav SA, Gaikwad RV, Gaonkar RK, Thorat VM, Balsara JJ.
    Indian J Physiol Pharmacol; 2007 Jan; 51(4):375-86. PubMed ID: 18476392
    [Abstract] [Full Text] [Related]

  • 10. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H, Sato H, Ida I, Oshima A, Sakurai N, Shihara N, Horikawa Y, Mikuni M.
    Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
    [Abstract] [Full Text] [Related]

  • 11. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
    Bartoszyk GD, Harting J, Minck KO.
    J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
    [Abstract] [Full Text] [Related]

  • 12. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
    Minematsu N.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
    [Abstract] [Full Text] [Related]

  • 13. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E, Krysiak R, Wieronska JM, Smialowska M, Herman ZS.
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [Abstract] [Full Text] [Related]

  • 14. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW, Bergman J.
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
    [Abstract] [Full Text] [Related]

  • 15. Effects of intrastriatal infusion of D2 receptor antisense oligonucleotide on apomorphine-induced behaviors in the rat.
    Rajakumar N, Laurier L, Niznik HB, Stoessl AJ.
    Synapse; 1997 Jul; 26(3):199-208. PubMed ID: 9183809
    [Abstract] [Full Text] [Related]

  • 16. An automated method for the assessment of spontaneous and stereotyped climbing behavior in mice. Effects of the selective D1- and D2-dopamine receptor agonists SKF-38393 and RU-24926 and their association.
    Simon P, Charpentier S, Costentin J.
    Methods Find Exp Clin Pharmacol; 1991 Mar; 13(2):99-104. PubMed ID: 1830125
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS, Yablonsky-Alter E, Lidsky TI, Banerjee SP.
    Eur J Pharmacol; 2008 Jun 10; 587(1-3):181-6. PubMed ID: 18457824
    [Abstract] [Full Text] [Related]

  • 18. Super-stereotypy II: enhancement of a complex movement sequence by intraventricular dopamine D1 agonists.
    Berridge KC, Aldridge JW.
    Synapse; 2000 Sep 01; 37(3):205-15. PubMed ID: 10881042
    [Abstract] [Full Text] [Related]

  • 19. D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period.
    Joyce JN.
    Synapse; 2001 May 01; 40(2):137-44. PubMed ID: 11252025
    [Abstract] [Full Text] [Related]

  • 20. Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists.
    Berridge KC, Aldridge JW.
    Synapse; 2000 Sep 01; 37(3):194-204. PubMed ID: 10881041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.